Awards & GrantsCollaborations & PartnershipsNF1NF2-SWNScience & ResearchSWN Announcing a New Award: Request for Data in NF Initiative
Collaborations & PartnershipsNF1Press ReleaseScience & Research EMA Accepts Submission for Koselugo (Selumetinib) as Treatment for Neurofibromatosis
AwarenessCollaborations & PartnershipsNF Clinic Network (NFCN)NF1NF2-SWNSWN Clinical Care Advisory Board meets in Atlanta
Awards & GrantsNF1PublicationsScience & Research Young Investigator Recipient Michelle Wegscheid Publishes Work in Stem Cell Reports
NF1Science & ResearchStory of NF Aidan Fraser Interviews Brigitte Widemann, MD about Selumetinib, the first FDA-Approved Drug for NF
